Abstract
Transcranial focused ultrasound (FUS) in conjunction with intravenous circulating ultrasound contrast agents (UCAs) or microbubbles (MBs) can promote a transient and spatiotemporally selective increase in blood-brain barrier (BBB) permeability. The coupling of FUS with image guidance, such as magnetic resonance imaging (MRI)-guided FUS (MRgFUS), can further facilitate the visualization of targeted, localized therapeutic delivery to the central nervous system (CNS), potentially revolutionizing current treatment approaches for a spectrum of neurological diseases and conditions. Targeted and effective treatments of numerous CNS diseases are hindered by the BBB, a neurovascular structural and biological interface impeding the transport of molecules, particles, and cells between the systemic circulation and the underlying brain tissues. The functionality of FUS in conjunction with UCAs or MBs to safely and reversibly disrupt the BBB has become an area of intense research efforts both preclinically and clinically. Clinical efforts related to this approach are currently underway in patients with brain tumors, early Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS). Critical ongoing issues include maintaining and monitoring safe levels of ultrasound exposure within different brain regions and tissues. Ongoing work related to real-time monitoring of the levels of acoustic energy deposition within brain regions warrants further investigation and integration into preclinical and clinical FUS systems. Despite the technological advancements in the field and the great promise of this new approach, there is a relative void in the knowledge pertaining to the underlying biological and molecular alterations induced by FUS in the brain. In this chapter, we review basic concepts of the BBB, the cellular and molecular composition of the BBB, the acoustic emissions and bio-effects associated with FUS-mediated activation of UCAs, and provide a summary of recent advances in strategies for detecting, controlling, and mapping FUS activity in the brain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Jones EG (1970) On the mode of entry of blood vessels into the cerebral cortex. J Anat 106(Pt 3):507–520
Rennels ML, Nelson E (Oct 1975) Capillary innervation in the mammalian central nervous system: an electron microscopic demonstration. Am J Anat 144(2):233–241. https://doi.org/10.1002/aja.1001440208
Cohen Z, Bonvento G, Lacombe P, Hamel E (Nov 1996) Serotonin in the regulation of brain microcirculation. Prog Neurobiol 50(4):335–362
Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci 5(5):347–360. https://doi.org/10.1038/nrn1387
Somlyo AP, Wu X, Walker LA, Somlyo AV (1999) Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol 134:201–234
Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4(5):399–414. https://doi.org/10.1038/nrn1106
del Zoppo GJ, Mabuchi T (2003) Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23(8):879–894. https://doi.org/10.1097/01.Wcb.0000078322.96027.78
Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7(1):41–53. https://doi.org/10.1038/nrn1824
Arvanitis CD, Ferraro GB, Jain RK (2019) The blood–brain barrier and blood–tumour barrier in brain tumours and metastases. Nat Rev Cancer 20(1):26–41. https://doi.org/10.1038/s41568-019-0205-x
Dubois LG et al (2014) Gliomas and the vascular fragility of the blood brain barrier. Front Cell Neurosci 8:418–418. https://doi.org/10.3389/fncel.2014.00418
Wolburg H, Noell S, Fallier-Becker P, Mack AF, Wolburg-Buchholz K (2012) The disturbed blood-brain barrier in human glioblastoma. Mol Aspects Med 33(5-6):579–589. https://doi.org/10.1016/j.mam.2012.02.003
Liebner S et al (2000) Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 100(3):323–331. https://doi.org/10.1007/s004010000180
Wolburg H et al (Jun 2003) Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105(6):586–592. https://doi.org/10.1007/s00401-003-0688-z
Medawar PB (Feb 1948) Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29(1):58–69
Billingham RE, Brent L, Medawar PB, Sparrow EM (1954) Quantitative studies on tissue transplantation immunity. I. The survival times of skin homografts exchanged between members of different inbred strains of mice. Proc R Soc Lond B Biol Sci 143(910):43–58
Billingham RE, Brent L, Medawar PB (1953) Actively acquired tolerance of foreign cells. Nature 172(4379):603–606. https://doi.org/10.1038/172603a0
Murphy JB, Sturm E (1923) Conditions determining the transplantability of tissues in the brain. J Exp Med 38(2):183–197. https://doi.org/10.1084/jem.38.2.183
Shirai Y (1921) On the transplantation of the rat sarcoma in adult heterogenous animals. Jpn Med World 1(14):14–15
Waksman BH, Adams RD (1955) Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 102(2):213–236. https://doi.org/10.1084/jem.102.2.213
Ransohoff RM, Engelhardt B (2012) The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12(9):623–635. https://doi.org/10.1038/nri3265
Shechter R et al (2013) Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 38(3):555–569. https://doi.org/10.1016/j.immuni.2013.02.012
Kipnis J, Gadani S, Derecki NC (2012) Pro-cognitive properties of T cells. Nat Rev Immunol 12(9):663–669. https://doi.org/10.1038/nri3280
Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M (2017) Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol 14(7):434–452. https://doi.org/10.1038/nrclinonc.2016.204
Ostrom QT et al (2015) CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol 17(Suppl 4):iv1–iv62. https://doi.org/10.1093/neuonc/nov189
Louis DN et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1
Mrdjen D et al (2018) High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48(2):380–395.e6. https://doi.org/10.1016/j.immuni.2018.01.011
Bechmann I et al (2001) Turnover of rat brain perivascular cells. Exp Neurol 168(2):242–249. https://doi.org/10.1006/exnr.2000.7618
Greter M, Lelios I, Croxford AL (2015) Microglia versus myeloid cell nomenclature during brain inflammation. Frontiers in Immunology, Short Survey 6:249. https://doi.org/10.3389/fimmu.2015.00249
Kivisakk P et al (2009) Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol 65(4):457–469. https://doi.org/10.1002/ana.21379
Ginhoux F et al (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330(6005):841–845. https://doi.org/10.1126/science.1194637
Schulz C et al (2012) A lineage of myeloid cells independent of myb and hematopoietic stem cells. Science 335(6077):86–90. https://doi.org/10.1126/science.1219179
Schreiner B, Heppner FL, Becher B (2009) Modeling multiple sclerosis in laboratory animals. Semin Immunopathol 31(4):479–495. https://doi.org/10.1007/s00281-009-0181-4
Louveau A et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523(7560):337–341. https://doi.org/10.1038/nature14432
Rankin LC, Artis D (2018) Beyond host defense: emerging functions of the immune system in regulating complex tissue physiology. Cell 173(3):554–567. https://doi.org/10.1016/j.cell.2018.03.013
Gadani SP, Smirnov I, Smith AT, Overall CC, Kipnis J (2017) Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury. J Exp Med 214(2):285–296. https://doi.org/10.1084/jem.20161982
Aspelund A et al (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212(7):991–999. https://doi.org/10.1084/jem.20142290
Louveau A et al (2018) CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci 21(10):1380–1391. https://doi.org/10.1038/s41593-018-0227-9
Antila S et al (2017) Development and plasticity of meningeal lymphatic vessels. J Exp Med 214(12):3645–3667. https://doi.org/10.1084/jem.20170391
Da Mesquita S et al (2018) Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560(7717):185–191. https://doi.org/10.1038/s41586-018-0368-8
Neuwelt E et al (2008) Strategies to advance translational research into brain barriers. Lancet Neurol 7(1):84–96
Kipnis J (2016) Multifaceted interactions between adaptive immunity and the central nervous system. Science 353(6301):766–771. https://doi.org/10.1126/science.aag2638
Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN (2015) Cancer stem cells in glioblastoma. Genes Dev 29(12):1203–1217. https://doi.org/10.1101/gad.261982.115
Hambardzumyan D, Amankulor NM, Helmy KY, Becher OJ, Holland EC (2009) Modeling Adult Gliomas Using RCAS/t-va Technology. Transl Oncol 2(2):89
Weller M et al (2015) Glioma. Nat Rev Dis Primers 1:15017. https://doi.org/10.1038/nrdp.2015.17
Phillips HS et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157–173. https://doi.org/10.1016/j.ccr.2006.02.019
Ellor SV, Pagano-Young TA, Avgeropoulos NG (2014) Glioblastoma: background, standard treatment paradigms, and supportive care considerations. J Law Med Ethics 42(2):171–182. https://doi.org/10.1111/jlme.12133
Thakkar JP et al (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23(10):1985–1996. https://doi.org/10.1158/1055-9965.Epi-14-0275
Ostrom QT et al (2014) The epidemiology of glioma in adults: a state of the science review. Neuro Oncol 16(7):896–913. https://doi.org/10.1093/neuonc/nou087
Blissitt PA (2014) Clinical practice guideline series update: care of the adult patient with a brain tumor. J Neurosci Nurs 46(6):367–368. https://doi.org/10.1097/jnn.0000000000000088
Westphal M, Lamszus K (Oct 2015) Circulating biomarkers for gliomas. Nat Rev Neurol 11(10):556–566. https://doi.org/10.1038/nrneurol.2015.171
Schweitzer T, Vince GH, Herbold C, Roosen K, Tonn JC (2001) Extraneural metastases of primary brain tumors. J Neurooncol 53(2):107–114. https://doi.org/10.1023/a:1012245115209
Bettegowda C et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6(224):224ra24. https://doi.org/10.1126/scitranslmed.3007094
Fleischhacker M, Schmidt B (2007) Circulating nucleic acids (CNAs) and cancer--a survey. Biochim Biophys Acta 1775(1):181–232. https://doi.org/10.1016/j.bbcan.2006.10.001
Alix-Panabieres C, Schwarzenbach H, Pantel K (2012) Circulating tumor cells and circulating tumor DNA. Annu Rev Med 63:199–215. https://doi.org/10.1146/annurev-med-062310-094219
Müller Bark J, Kulasinghe A, Chua B, Day BW, Punyadeera C (2019) Circulating biomarkers in patients with glioblastoma. British Journal of Cancer 122(3):295–305. https://doi.org/10.1038/s41416-019-0603-6
Best MG, Sol N, Zijl S, Reijneveld JC, Wesseling P, Wurdinger T (2015) Liquid biopsies in patients with diffuse glioma. Acta Neuropathol 129(6):849–865. https://doi.org/10.1007/s00401-015-1399-y
Rennert RC, Hochberg FH, Carter BS (2016) ExRNA in biofluids as biomarkers for brain tumors. Cell Mol Neurobiol 36(3):353–360. https://doi.org/10.1007/s10571-015-0284-5
Muller C et al (2014) Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 6(247):247ra101. https://doi.org/10.1126/scitranslmed.3009095
T. C. G. A. T. R. Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061–1068. https://doi.org/10.1038/nature07385
Parsons DW et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807–1812. https://doi.org/10.1126/science.1164382
Chow LML et al (2011) Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer cell 19(3):305–316. https://doi.org/10.1016/j.ccr.2011.01.039
Alifieris C, Trafalis DT (2015) "glioblastoma multiforme: pathogenesis and treatment," (in eng). Pharmacol Ther 152:63–82. https://doi.org/10.1016/j.pharmthera.2015.05.005
Wilson TA, Karajannis MA, Harter DH (2014) Glioblastoma multiforme: state of the art and future therapeutics. Surg Neurol Int 5:64. https://doi.org/10.4103/2152-7806.132138
Young RM, Jamshidi A, Davis G, Sherman JH (2015) Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med 3(9):121. https://doi.org/10.3978/j.issn.2305-5839.2015.05.10
Brennan CW et al (2013) The somatic genomic landscape of glioblastoma. Cell 155(2):462–477. https://doi.org/10.1016/j.cell.2013.09.034
Verhaak RG et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98–110. https://doi.org/10.1016/j.ccr.2009.12.020
Wang H et al (2015) The challenges and the promise of molecular targeted therapy in malignant gliomas. Neoplasia 17(3):239–255. https://doi.org/10.1016/j.neo.2015.02.002
Dirkse A et al (2019) Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nat Commun 10(1):1787. https://doi.org/10.1038/s41467-019-09853-z
Wick W, Kessler T (2018) New glioblastoma heterogeneity atlas — a shared resource. Nature Reviews Neurology 14(8):453–454. https://doi.org/10.1038/s41582-018-0038-3
Garnier D, Renoult O, Alves-Guerra M-C, Paris F, Pecqueur C (2019) Glioblastoma stem-like cells, metabolic strategy to kill a challenging target. Front Oncol 9:118. https://doi.org/10.3389/fonc.2019.00118
Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330
Wick W, Wick A, Schulz JB, Dichgans J, Rodemann HP, Weller M (2002) Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. Cancer Res 62(6):1915
Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME (2007) Molecular targets of glioma invasion. Cell Mol Life Sci 64(4):458. https://doi.org/10.1007/s00018-007-6342-5
Grossman SA et al (2003) Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 21(8):1485–1491. https://doi.org/10.1200/jco.2003.10.035
Ewing JR et al (2006) Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor. J Cereb Blood Flow Metab 26(3):310–320. https://doi.org/10.1038/sj.jcbfm.9600189
Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP (Jul 1982) Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci U S A 79(14):4420–4423. https://doi.org/10.1073/pnas.79.14.4420
Groothuis DR, Fischer JM, Lapin G, Bigner DD, Vick NA (Mar 1982) Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol 41(2):164–185. https://doi.org/10.1097/00005072-198203000-00006
Neuwelt EA et al (1985) Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier. Cancer Res 45(6):2827–2833
Burger PC (1987) The anatomy of astrocytomas. Mayo Clin Proc 62(6):527–529. https://doi.org/10.1016/s0025-6196(12)65479-2
Halperin EC, Burger PC, Bullard DE (1988) The fallacy of the localized supratentorial malignant glioma. Int J Radiat Oncol Biol Phys 15(2):505–509. https://doi.org/10.1016/s0360-3016(98)90036-0
Liu H-L, Fan C-H, Ting C-Y, Yeh C-K (2014) Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview. Theranostics 4(4):432–444. https://doi.org/10.7150/thno.8074
Korpanty G, Grayburn PA, Shohet RV, Brekken RA (2005) Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol 31(9):1279–1283. https://doi.org/10.1016/j.ultrasmedbio.2005.06.001
Singhal S, Moser CC, Wheatley MA (1993) Surfactant-stabilized microbubbles as ultrasound contrast agents: stability study of Span 60 and Tween 80 mixtures using a Langmuir trough. Langmuir 9(9):2426–2429. https://doi.org/10.1021/la00033a027
Wang W, Moser CC, Wheatley MA (1996) Langmuir trough study of surfactant mixtures used in the production of a new ultrasound contrast agent consisting of stabilized microbubbles. J Phys Chem 100(32):13815–13821. https://doi.org/10.1021/jp9613549
Mehta AI et al (2012) Convection enhanced delivery of macromolecules for brain tumors. Curr Drug Discov Technol 9(4):305–310
Bruce JN et al (2011) Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery 69(6):1272–1279; discussion 1279-80. https://doi.org/10.1227/NEU.0b013e3182233e24
Pollina J et al (1998) Intratumoral infusion of topotecan prolongs survival in the nude rat intracranial U87 human glioma model. J Neurooncol 39(3):217–225. https://doi.org/10.1023/a:1005954121521
Lonser RR et al (2007) Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology 68(4):254–261. https://doi.org/10.1212/01.wnl.0000247744.10990.e6
Shahar T, Ram Z, Kanner AA (2012) Convection-enhanced delivery catheter placements for high-grade gliomas: complications and pitfalls. J Neurooncol 107(2):373–378. https://doi.org/10.1007/s11060-011-0751-x
Dressaire E, Bee R, Bell DC, Lips A, Stone HA (2008) Interfacial polygonal nanopatterning of stable microbubbles. Science 320(5880):1198–1201. https://doi.org/10.1126/science.1154601
Myrset AH, Nicolaysen H, Toft K, Christiansen C, Skotland T (1996) Structure and organization of albumin molecules forming the shell of air-filled microspheres: evidence for a monolayer of albumin molecules of multiple orientations stabilizing the enclosed air. Biotechnol Appl Biochem 24(2):145–153
Pattle RE (1955) Properties, function and origin of the alveolar lining layer. Nature 175(4469):1125–1126. https://doi.org/10.1038/1751125b0
Lonser RR, Gogate N, Morrison PF, Wood JD, Oldfield EH (1998) Direct convective delivery of macromolecules to the spinal cord. J Neurosurg 89(4):616–622. https://doi.org/10.3171/jns.1998.89.4.0616
Sprowls SA et al (2019) Improving CNS delivery to brain metastases by blood-tumor barrier disruption. Trends Cancer 5(8):495–505. https://doi.org/10.1016/j.trecan.2019.06.003
Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220(3):640–646
Wei KC et al (2013) Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study. PLos One 8(3):e58995. https://doi.org/10.1371/journal.pone.0058995
White PJ, Clement GT, Hynynen K (2006) Longitudinal and shear mode ultrasound propagation in human skull bone. Ultrasound Med Biol 32(7):1085–1096. https://doi.org/10.1016/j.ultrasmedbio.2006.03.015
Jones RM, O’Reilly MA, Hynynen K (2014) Passive mapping of acoustic sources within the human skull cavity with a hemispherical sparse array using computed tomography-based aberration corrections. J Acoust Soc Am 135(4):2208–2209. https://doi.org/10.1121/1.4877211
Tanter M, Thomas JL, Fink M (1998) Focusing and steering through absorbing and aberrating layers: application to ultrasonic propagation through the skull. J Acoust Soc Am 103(5 Pt 1):2403–2410. https://doi.org/10.1121/1.422759
Hynynen K, Jolesz FA (1998) Demonstration of potential noninvasive ultrasound brain therapy through an intact skull. Ultrasound Med Biol 24(2):275–283. https://doi.org/10.1016/s0301-5629(97)00269-x
McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS (2012) Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res 72(14):3652–3663. https://doi.org/10.1158/0008-5472.Can-12-0128
Clement GT, Hynynen K (2002) A non-invasive method for focusing ultrasound through the human skull. Phys Med Biol 47(8):1219–1236. https://doi.org/10.1088/0031-9155/47/8/301
Hynynen K et al (2006) Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain--a primate study. Eur J Radiol 59(2):149–156. https://doi.org/10.1016/j.ejrad.2006.04.007
Marquet F et al (2009) Non-invasive transcranial ultrasound therapy based on a 3D CT scan: protocol validation and in vitro results. Phys Med Biol 54(9):2597–2613. https://doi.org/10.1088/0031-9155/54/9/001
Chauvet D et al (2013) Targeting accuracy of transcranial magnetic resonance-guided high-intensity focused ultrasound brain therapy: a fresh cadaver model. J Neurosurg 118(5):1046–1052. https://doi.org/10.3171/2013.1.Jns12559
Aubry JF, Tanter M, Pernot M, Thomas JL, Fink M (2003) Experimental demonstration of noninvasive transskull adaptive focusing based on prior computed tomography scans. J Acoust Soc Am 113(1):84–93. https://doi.org/10.1121/1.1529663
Miller GW, Eames M, Snell J, Aubry J-F (2015) Ultrashort echo-time MRI versus CT for skull aberration correction in MR-guided transcranial focused ultrasound: In vitro comparison on human calvaria. Med Phys 42(5):2223. https://doi.org/10.1118/1.4916656
Sassaroli E, Hynynen K (2005) Resonance frequency of microbubbles in small blood vessels: a numerical study. Phys Med Biol 50(22):5293–5305. https://doi.org/10.1088/0031-9155/50/22/006
Hosseinkhah N, Hynynen K (2012) A three-dimensional model of an ultrasound contrast agent gas bubble and its mechanical effects on microvessels. Phys Med Biol 57(3):785–808. https://doi.org/10.1088/0031-9155/57/3/785
McDannold N, Vykhodtseva N, Hynynen K (2006) Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol 51(4):793–807. https://doi.org/10.1088/0031-9155/51/4/003
Tung YS, Vlachos F, Choi JJ, Deffieux T, Selert K, Konofagou EE (2010) In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice. Phys Med Biol 55(20):6141–6155. https://doi.org/10.1088/0031-9155/55/20/007
Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N (2012) Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS One 7(9):e45783. https://doi.org/10.1371/journal.pone.0045783
Tung YS, Marquet F, Teichert T, Ferrera V, Konofagou EE (2011) Feasibility of noninvasive cavitation-guided blood-brain barrier opening using focused ultrasound and microbubbles in nonhuman primates. Appl Phys Lett 98(16):163704. https://doi.org/10.1063/1.3580763
O’Reilly MA, Hynynen K (2012) Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology 263(1):96–106. https://doi.org/10.1148/radiol.11111417
Aryal M, Arvanitis CD, Alexander PM, McDannold N (2014) Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. Adv Drug Deliv Rev 72:94–109. https://doi.org/10.1016/j.addr.2014.01.008
Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K (2012) Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 38(10):1716–1725. https://doi.org/10.1016/j.ultrasmedbio.2012.04.015
Yang FY et al (2012) Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound. PLoS One 7(9):e45468. https://doi.org/10.1371/journal.pone.0045468
Lin CY et al (2015) Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery. J Control Release 212:1–9. https://doi.org/10.1016/j.jconrel.2015.06.010
Lin CY et al (2016) Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson’s disease mouse model. J Control Release 235:72–81. https://doi.org/10.1016/j.jconrel.2016.05.052
Zhao G et al (2018) Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth. Cancer Lett 418:147–158. https://doi.org/10.1016/j.canlet.2018.01.035
Mead BP, Mastorakos P, Suk JS, Klibanov AL, Hanes J, Price RJ (2016) Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound. J Control Release 223:109–117. https://doi.org/10.1016/j.jconrel.2015.12.034
Fisher DG, Price RJ (2019) Recent advances in the use of focused ultrasound for magnetic resonance image-guided therapeutic nanoparticle delivery to the central nervous system. Front Pharmacol 10:1348. https://doi.org/10.3389/fphar.2019.01348
Luo Z et al (2017) On-demand drug release from dual-targeting small nanoparticles triggered by high-intensity focused ultrasound enhanced glioblastoma-targeting therapy. ACS Appl Mater Interfaces 9(37):31612–31625. https://doi.org/10.1021/acsami.7b10866
Brightman MW (1977) Morphology of blood-brain interfaces. Exp Eye Res 25:1–25. https://doi.org/10.1016/S0014-4835(77)80008-0
Pardridge WM (2002) Drug and gene targeting to the brain with molecular trojan horses. Nat Rev Drug Discov 1(2):131–139. https://doi.org/10.1038/nrd725
Acknowledgments
This work was supported, in part, by the National Institutes of Health (T32 Training Grant in Cancer Biology 5T32CA154274, R01NS107813, and R21NS113016) and the Focused Ultrasound Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Anastasiadis, P., Winkles, J.A., Kim, A.J., Woodworth, G.F. (2021). Focused Ultrasound-Mediated Blood-Brain Barrier Disruption for Enhanced Drug Delivery to Brain Tumors. In: Agrahari, V., Kim, A., Agrahari, V. (eds) Nanotherapy for Brain Tumor Drug Delivery. Neuromethods, vol 163. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1052-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1052-7_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1051-0
Online ISBN: 978-1-0716-1052-7
eBook Packages: Springer Protocols